RNA toxicity is a component of ataxin-3 degeneration in Drosophila

被引:243
|
作者
Li, Ling-Bo [1 ]
Yu, Zhenming [1 ,2 ]
Teng, Xiuyin [1 ,2 ]
Bonini, Nancy M. [1 ,2 ]
机构
[1] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1038/nature06909
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes(1). The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis(2,3). Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases(4-6). Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.
引用
收藏
页码:1107 / U9
页数:6
相关论文
共 50 条
  • [31] Hydrostatic pressure effects on the stability of ataxin-3
    Marchal, SP
    Shehi, E
    Fusi, P
    Tortora, P
    Lange, R
    ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY II, PROCEEDINGS, 2003, : 73 - 77
  • [32] PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner
    Jia N.-L.
    Fei E.-K.
    Ying Z.
    Wang H.-F.
    Wang G.-H.
    Neuroscience Bulletin, 2008, 24 (4) : 201 - 208
  • [33] Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA
    Li, Y
    Yokota, T
    Matsumura, R
    Taira, K
    Mizusawa, H
    ANNALS OF NEUROLOGY, 2004, 56 (01) : 124 - 129
  • [34] Mutant ataxin-3 promotes the autophagic degradation of parkin
    Durcan, Thomas M.
    Fon, Edward A.
    AUTOPHAGY, 2011, 7 (02) : 233 - 234
  • [35] Ataxin-3 Is a Multivalent Ligand for the Parkin Ubl Domain
    Bai, Jane J.
    Safadi, Susan S.
    Mercier, Pascal
    Barber, Kathryn R.
    Shaw, Gary S.
    BIOCHEMISTRY, 2013, 52 (42) : 7369 - 7376
  • [36] Mutant ataxin-3 alters the functional organization of the nucleus
    Sun, J
    Xu, HZ
    Subramony, S
    Hebert, M
    FASEB JOURNAL, 2006, 20 (04): : A68 - A68
  • [37] Trehalose prevents the formation of aggregates of mutant ataxin-3 and reduces soluble ataxin-3 protein levels in an SCA3 cell model
    Wang, Zijian
    Wang, Min
    Huang, Yuhang
    Ma, Zhiwei
    Gao, Wenjing
    Zhang, Tian
    Deng, Jiexin
    Cheng, Xiaoxia
    Liu, Yingxun
    Wang, Bo
    Qi, Ying
    Yang, Min
    He, Fengqin
    NEUROSCIENCE, 2024, 555 : 76 - 82
  • [38] NEDD8:: A new ataxin-3 interactor
    Ferro, Anabela
    Carvalho, Ana Luisa
    Teixeira-Castro, Andrela
    Almeida, Carla
    Tome, Ricardo J.
    Cortes, Luisa
    Rodrigues, Ana-Joao
    Logarinho, Elsa
    Sequeiros, Jorge
    Macedo-Ribeiro, Sandra
    Maciel, Patricia
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (11): : 1619 - 1627
  • [39] Proteotoxic stress increases nuclear localization of ataxin-3
    Reina, Christopher P.
    Zhong, Xiaoyan
    Pittman, Randall N.
    HUMAN MOLECULAR GENETICS, 2010, 19 (02) : 235 - 249
  • [40] Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3
    Johnson, Sean L.
    Libohova, Kozeta
    Blount, Jessica R.
    Sujkowski, Alyson L.
    Prifti, Matthew, V
    Tsou, Wei-Ling
    Todi, Sokol, V
    NEUROBIOLOGY OF DISEASE, 2021, 160